Limbal Stem Cell Derived Exosome (LSC-Exo) Eye Drop for Treatment of Dry Eye

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

July 1, 2026

Conditions
Dry Eye Syndromes
Interventions
BIOLOGICAL

Limbal Stem Cell Derived Exosomes Eye Drop

Patients will receive artificial tears for 2 weeks to get the normalized baseline, followed by LSC-Exo eye drops 0.15 ml/single eye/one time, four times a day for 3 months. The follow-up visit will be 12 weeks since the administration of LSC-Exo eye drops.

Trial Locations (1)

Unknown

RECRUITING

Moheb Kowsar Hospital, Tehran

All Listed Sponsors
lead

Iran University of Medical Sciences

OTHER